Back

Extra cellular volume by computed tomography is useful for prediction of prognosis in cardiac sarcoidosis

1 September 2024 (08:55 - 09:05)
Organised by: Logo
Congress Presentation Part of: Imaging to improve diagnosis and risk-stratification of cardiomyopathies Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yusei Nishikawa

Chiba University Hospital, Chiba (Japan)

5 More presentations in this session

Presentation thumbnail
Long-term outcomes of patients with apical hypertrophic cardiomyopathy: incorporation of a novel risk score.
Doctor M. Desai (Cleveland, US)
Abstract Slides Video
Presentation thumbnail
Identification and validation of ventricular rhythmic risk subgroups in hypertrophic cardiomyopathy by clustering analysis including left ventricular strain analysis
Doctor A. Al wazzan (Rennes, FR)
Abstract Slides Video
Presentation thumbnail
Automated deep learning approach for identifying etiologies of hypertrophic phenocopies by echocardiography
Mr P. Su (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Artificial intelligence-guided screening of under-recognized cardiomyopathies adapted for point-of-care echocardiography
Doctor E. Oikonomou (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Arrhythmogenic right ventricular cardiomyopathy: the importance of biventricular strain in risk-stratification
Doctor A. Chua (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging to improve diagnosis and risk-stratification of cardiomyopathies
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 08:55 CET
You may be interested in
thumbnail
Congress Session
Computed tomography assessment of myocardial disease revisited
thumbnail
Congress Session
Cardiovascular magnetic resonance: advances that can impact on clinical practice
thumbnail
Congress Presentation
Associate variables of coronary computed tomographic angiography-derived extracellular volume fraction and cardiac magnetic resonance-derived late-gadolinium enhancement

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources